Dramatic hyperleukocytosis after treatment of myelodysplastic syndrome with pegfilgrastim and darbepoetin-alfa

被引:5
|
作者
Heydrich, Bjoern-N [1 ]
Schoch, Robert [1 ]
Horst, Heinz-August [1 ]
Kneba, Michael [1 ]
机构
[1] Univ Hosp Schleswig Holstein, Dept Internal Med & Hematol 2, Lubeck, Germany
关键词
D O I
10.1007/s00277-007-0364-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:77 / 78
页数:2
相关论文
共 50 条
  • [1] Dramatic hyperleukocytosis after treatment of myelodysplastic syndrome with pegfilgrastim and darbepoetin-alfa
    Bjoern-N Heydrich
    Robert Schoch
    Heinz-August Horst
    Michael Kneba
    [J]. Annals of Hematology, 2008, 87 : 77 - 78
  • [2] Successful treatment of a patient with myelodysplastic syndrome (RAEB) with Darbepoetin-alfa in combination with Pegfilgrastim
    Jakob, A
    Hirsch, FW
    Engelhardt, M
    [J]. ANNALS OF HEMATOLOGY, 2005, 84 (10) : 694 - 695
  • [3] Successful treatment of a patient with myelodysplastic syndrome (RAEB) with Darbepoetin-alfa in combination with Pegfilgrastim
    Andreas Jakob
    Friedrich W. Hirsch
    Monika Engelhardt
    [J]. Annals of Hematology, 2005, 84 : 694 - 695
  • [4] Darbepoetin alfa for anemia with myelodysplastic syndrome
    Seastone, David J.
    Gerds, Aaron T.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) : 139 - 146
  • [5] Darbepoetin alfa for the treatment of anemia in patients with myelodysplastic syndrome.
    Giraldo, P
    Nomdedeu, B
    Loscertales, J
    Requena, C
    de Paz, R
    Tormo, M
    Navarro, P
    Benedit, P
    Gasquet, JA
    [J]. BLOOD, 2005, 106 (11) : 714A - 714A
  • [7] HEMOGLOBIN VARIABILITY IS ASSOCIATED WITH NUTRITIONAL STATUS IN HEMODIALYSIS PATIENTS UNDERGOING DARBEPOETIN-ALFA TREATMENT
    Kim, Do Hyoung
    Shin, Jungho
    Oh, Dong-Jin
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I818 - I818
  • [8] Use of darbepoetin alfa for myelodysplastic syndrome coincident with chronic kidney disease
    Kei Nagai
    Kunihiro Yamagata
    [J]. CEN Case Reports, 2016, 5 (1) : 117 - 118
  • [9] Use of darbepoetin alfa for myelodysplastic syndrome coincident with chronic kidney disease
    Nagai, Kei
    Yamagata, Kunihiro
    [J]. CEN CASE REPORTS, 2016, 5 (01): : 117 - +
  • [10] Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of life
    Oliva, Esther N.
    Nobile, Francesco
    Alimena, Giuliana
    Specchia, Giorgina
    Danova, Marco
    Rovati, Bianca
    Ronco, Francesca
    Impera, Stefana
    Risitano, Antonio
    Alati, Caterina
    Breccia, Massimo
    Carmosino, Ida
    Vincelli, Iolanda
    Latagliata, Roberto
    [J]. LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1007 - 1014